Non-compliance and discontinuation increases the risk of cardiovascular events in patients receiving low-dose aspirin

Herlitz J., Toth P.P., Naesdal J., Low-dose aspirin therapy for cardiovascular prevention: Quantification and consequences of poor compliance or discontinuation, Am. J. Cardiovasc. Drugs, 10, 2, pp. 125-41, (2010)

Campbell C.L., Smyth S., Montalescot G., Steinhubl S.R., Aspirin dose for the prevention of cardiovascular disease: A systematic review, Journal of the American Medical Association, 297, 18, pp. 2018-2024, (2007)

McFadden E.P., Stabile E., Regar E., Cheneau E., Ong A.T.L., Kinnaird T., Suddath W.O., Weissman N.J., Torguson R., Kent K.M., Pichard A.D., Satler L.F., Waksman R., Serruys P.W., Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy, Lancet, 364, 9444, pp. 1519-1521, (2004)

Aguejouf O., Eizayaga F., Desplat V., Et al., Prothrombotic and hemorrhagic effects of aspirin, Clin. Appl. Thromb. Hemost., 15, 5, pp. 523-8, (2009)

Morant S.V., McMahon A.D., Cleland J.G., Et al., Cardiovascular prophylaxis with aspirin: Costs of supply and management of upper gastrointestinal and renal toxicity, Br. J. Clin. Pharmacol., 57, 2, pp. 188-98, (2004)

Laheij R.J., Jansen J.B., Verbeek A.L., Et al., Helicobacter pylori infection as a risk factor for gastrointestinal symptoms in patients using aspirin to prevent ischaemic heart disease, Aliment Pharmacol. Ther., 15, 7, pp. 1055-9, (2001)

Wang Y., Wu D., Wang Y., Ma R., Wang C., Zhao W., A survey on adherence to secondary ischemic stroke prevention, Neurological Research, 28, 1, pp. 16-20, (2006)

De Schryver E.L.L.M., Van Gijn J., Kappelle L.J., Koudstaal P.J., Algra A., Non-adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke, Journal of Neurology, 252, 11, pp. 1316-1321, (2005)

Sappok T., Faulstich A., Stuckert E., Kruck H., Marx P., Koennecke H.-C., Compliance with secondary prevention of ischemic stroke a prospective evaluation, Stroke, 32, 8, pp. 1884-1889, (2001)

Ferrari E., Benhamou M., Cerboni P., Marcel B., Coronary syndromes following aspirin withdrawal: A special risk for late stent thrombosis, Journal of the American College of Cardiology, 45, 3, pp. 456-459, (2005)

Herlitz J., Toth P.P., Naesdal J., Low-dose aspirin therapy for cardiovascular prevention: Quantification and consequences of poor compliance or discontinuation, Am. J. Cardiovasc. Drugs, 10, 2, pp. 125-41, (2010)

Campbell C.L., Smyth S., Montalescot G., Steinhubl S.R., Aspirin dose for the prevention of cardiovascular disease: A systematic review, Journal of the American Medical Association, 297, 18, pp. 2018-2024, (2007)

McFadden E.P., Stabile E., Regar E., Cheneau E., Ong A.T.L., Kinnaird T., Suddath W.O., Weissman N.J., Torguson R., Kent K.M., Pichard A.D., Satler L.F., Waksman R., Serruys P.W., Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy, Lancet, 364, 9444, pp. 1519-1521, (2004)

Aguejouf O., Eizayaga F., Desplat V., Et al., Prothrombotic and hemorrhagic effects of aspirin, Clin. Appl. Thromb. Hemost., 15, 5, pp. 523-8, (2009)

Morant S.V., McMahon A.D., Cleland J.G., Et al., Cardiovascular prophylaxis with aspirin: Costs of supply and management of upper gastrointestinal and renal toxicity, Br. J. Clin. Pharmacol., 57, 2, pp. 188-98, (2004)

Laheij R.J., Jansen J.B., Verbeek A.L., Et al., Helicobacter pylori infection as a risk factor for gastrointestinal symptoms in patients using aspirin to prevent ischaemic heart disease, Aliment Pharmacol. Ther., 15, 7, pp. 1055-9, (2001)

Wang Y., Wu D., Wang Y., Ma R., Wang C., Zhao W., A survey on adherence to secondary ischemic stroke prevention, Neurological Research, 28, 1, pp. 16-20, (2006)

De Schryver E.L.L.M., Van Gijn J., Kappelle L.J., Koudstaal P.J., Algra A., Non-adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke, Journal of Neurology, 252, 11, pp. 1316-1321, (2005)

Sappok T., Faulstich A., Stuckert E., Kruck H., Marx P., Koennecke H.-C., Compliance with secondary prevention of ischemic stroke a prospective evaluation, Stroke, 32, 8, pp. 1884-1889, (2001)

Ferrari E., Benhamou M., Cerboni P., Marcel B., Coronary syndromes following aspirin withdrawal: A special risk for late stent thrombosis, Journal of the American College of Cardiology, 45, 3, pp. 456-459, (2005)